tridemorph has been researched along with Adenocarcinoma, Mucinous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hishida, T; Ichinokawa, H; Ishii, G; Kawase, A; Nagai, K; Nishimura, M; Ochiai, A; Ogasawara, N; Tsuchihara, K; Yoshida, J | 1 |
| Fukushima, N; Hirohashi, S; Sakamoto, M | 1 |
2 other study(ies) available for tridemorph and Adenocarcinoma, Mucinous
| Article | Year |
|---|---|
Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation.
Topics: Adenocarcinoma, Mucinous; Aged; Aged, 80 and over; Cell Adhesion Molecules; ErbB Receptors; Female; Geminin; Humans; Kalinin; Lung; Lung Neoplasms; Male; Matrix Metalloproteinase 7; Middle Aged; Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins | 2013 |
Expression of laminin-5-gamma-2 chain in intraductal papillary-mucinous and invasive ductal tumors of the pancreas.
Topics: Adenocarcinoma, Mucinous; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Cell Adhesion Molecules; Cystadenoma, Mucinous; Cystadenoma, Papillary; Fluorescent Antibody Technique, Indirect; Humans; Kalinin; Pancreatic Neoplasms | 2001 |